21 May 2015
Feeble EU demand is not the only thing ailing Chinese exporters. They are also contending with a rising cost-base and stronger overseas competitors.
Ongoing mistrust of domestic infant milk formula brands following a string of safety scandals has proved a boon for multinational producers in this fast-growing, defensive sector.
As one of the few domestic infant formula makers not to be tainted by scandal, Beingmate has potential to grow, especially once a new production facility comes online later this year
The proposed acquisition of Pfizer Nutrition will boost Nestle’s faltering attempts to tap into China’s infant formula milk market.
Danone’s Dumex brand is the number-two infant milk formula brand in China, but the French food giant is failing to exploit the growing popularity of its unofficially imported products.
Domestic formula milk maker Yashili has failed to reassure higher-tier consumers about the safety of its products following its implication in the 2008 melamine scandal.
The number-one infant milk formula maker in China is suffering a sales slowdown, but its long-term growth prospects remain strong.
A proposed revision to China’s Budget Law that would have enabled local governments to issue bonds directly has been delayed, generating heated debate among economists and academics
A pilot scheme to replace business tax with value-added tax in several provinces could help ease the tax burden for service-sector companies.